510(k) K973882
- Device
- EL-B2GP1SCR
- Applicant
- THERATEST LABORATORIES, INC.
- 510(k) number
- K973882
- Product code
- MSV
- Decision
- Substantially Equivalent (SESE)
- Decision date
- 1997-12-05
- Date received
- 1997-10-14
- Regulation
- 866.5660
- Classification name
- System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)
- Medical specialty
- Immunology
- Review panel
- Immunology
- Device class
- 2
- Clearance type
- Traditional
- Statement or summary
- Statement
- Third party reviewed
- No
Applicant Contact#
- Contact
- MARIUS TEODORESCU
- Address
- 2201 W. Campbell Park Dr. Chicago IL US 60612 60612
FDA Registration Numbers#
- 3003825930
- 1421346
- 3032705
- 1721937
- 3039353646
- 8043792
- 3004973408
- 9680745
- 1217183
- 1832216
- 2915274
- 1529254
- 1181055
- 1222302
- 2026994
- 9610566
- 3012348571
- 9610746
- 3037000637
Source Documents#
510(k) summary PDF not indicated by FDA
Other 510(k) Records For Product Code MSV #
| 510(k) | Device | Applicant | Decision date |
|---|---|---|---|
| K243979 | Aptiva APS IgA Reagent | Inova Diagnostics, Inc. | 2026-02-06 |
| K181329 | EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA Immunoassay | Phadia AB | 2018-06-25 |
| K162788 | ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA | Immco Diagnostics, Inc. | 2017-06-19 |
| K152875 | QUANTA Flash B2GP1-Domain1, QUANTA Flash B2GP1-Domain1 Controls, HemosIL AcuStar Anti-B2GPI Domain 1, HemosIL AcuStar Anti-B2GPI Domain 1 Controls | Inova Diagnostics, Inc. | 2015-12-21 |
| K141274 | QUANTA FLASH ¿2GP1-DOMAIN1; CONTROLS, HEMOSIL ACUSTAR ANTI-¿2GPI DOMAIN1; CONTROLS. | Inova Diagnostics, Inc. | 2015-02-13 |
| K112414 | ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAY | Phadia US, Inc. | 2012-06-22 |
| K091556 | HEMOSIL ACUSTAR ANTI-B2 GLYCOPROTEIN-I; IGG, IGM, IGG CONTROLS, IGM CONTROLS | Instrumentation Laboratory CO | 2010-05-21 |
| K092757 | THERATEST EL-BETA2GPI (IGM-IGG-IGA), THERATEST EL--BETA2GPI SCR | Thera-Test Laboratories, Inc. | 2009-10-09 |
| K072032 | IGG ANTI-ATHEROX TEST KIT | Corgenix, Inc. | 2008-04-04 |
| K062217 | AESKULSKA BETA2-GLYCO-A | Aesku, Inc. | 2006-12-13 |
| K040449 | VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 18796 | Pharmacia Deutschland GmbH | 2004-05-11 |
| K040450 | VARELISA B2 GLYCOPROTEIN I IGA ANTIBODIES, MODELS 18948 AND 18996 | Pharmacia Deutschland GmbH | 2004-05-11 |
| K040451 | VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896 | Pharmacia Deutschland GmbH | 2004-05-11 |
| K040452 | VARELISA B2 GLYCOPROTEIN I ANTIBODIES SCREEN, MODELS 19048 AND 19096 | Pharmacia Deutschland GmbH | 2004-05-11 |
| K030701 | IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGG ELISA | Immco Diagnostics, Inc. | 2003-09-09 |
Legacy Summary#
Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links Follow FDA En Español Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products FDA Home Medical Devices Databases
FDA Review#
Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links Follow FDA En Español Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products FDA Home Medical Devices Databases